Physician profile
Alicia D Devore
NPI 1467687384
$660.37
in general payments reported to CMS, 2019-2025
18 companies · $552 in 2025
The $552 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $109 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $90.19 | 2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $67.90 | 2025 | |
| Neurocrine Biosciences, INC. | $59.72 | 2025 | |
| Abbott Laboratories | $55.53 | 2024-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $48.18 | 2024-2025 | Ozempic, Rybelsus |
| Beta Bionics, INC. | $45.17 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amgen INC. | $41.40 | 2025 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.38 | 2024-2025 | Jardiance |
| Ascendis Pharma Endocrinology INC | $36.10 | 2025 | Yorvipath |
| Recordati_rare_diseases_inc. | $27.46 | 2025 | Isturisa |
| Sanofi-Aventis U.S. LLC | $25.73 | 2025 | |
| Dexcom, INC. | $21.87 | 2024 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $20.11 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $18.18 | 2025 | Recorlev |
| Ascensia Diabetes Care US INC. | $17.65 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $17.09 | 2025 | Strensiq |
| Abbvie INC. | $16.21 | 2025 | |
| Cequr Corporation | $14.50 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Devore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.